Ticker

ANTX

AN2 Therapeutics, Inc.

4 catalysts on file

ANTX

AN2 Therapeutics, Inc.

Phase 1 AI-extracted

oral AN2-502998

Chagas disease

306d ago Jan 1, 2026

SEC 8-K verified 4mo ago

Countdown card →

ANTX

AN2 Therapeutics, Inc.

Phase 2 AI-extracted

oral AN2-502998

Chagas disease

126d ago ~ Jun 30, 2026

SEC 8-K verified 4mo ago

Countdown card →

ANTX

AN2 Therapeutics, Inc.

Phase 2 AI-extracted

oral epetraborole

polycythemia vera

T-minus 58 days ~ Dec 31, 2026

SEC 8-K verified 4mo ago

Countdown card →

ANTX

AN2 Therapeutics, Inc.

Phase 2 AI-extracted

epetraborole

M. abscessus complex lung disease

T-minus 239 days ~ Jun 30, 2027

SEC 8-K verified 4mo ago

Countdown card →